OG'IZ MIKROBIOTASIDAGI O'ZGARISHLAR VA UNING YURAK, DIABET VA BOSHQA TIZIMLI KASALLIKLAR BILAN BOG'LIQLIGI

This study explores the emerging evidence linking alterations in oral microbiota with systemic diseases, including cardiovascular disorders, diabetes, and metabolic syndrome [1, 2]. Dysbiosis of the oral microbiome can lead to chronic inflammation, increased oxidative stress, and immune dysregulation, which may contribute to the pathogenesis of systemic conditions [3, 4]. Research indicates that specific bacterial species, such as Porphyromonas gingivalis and Fusobacterium nucleatum, play a key role in promoting atherosclerosis, insulin resistance, and other metabolic disturbances [2, 5]. Understanding the complex interactions between oral microorganisms and systemic health may facilitate the development of predictive biomarkers and targeted interventions, emphasizing the importance of oral hygiene and preventive dental care in maintaining overall health [1, 3].本研究探讨了口腔菌群改变与系统性疾病之间关联的新兴证据，此类系统性疾病涵盖心血管疾病、糖尿病与代谢综合征[1,2]。口腔微生物群（oral microbiome）失调可引发慢性炎症、氧化应激水平升高及免疫功能紊乱，上述变化可能参与多种全身性疾病的发病进程[3,4]。研究显示，特定菌种如牙龈卟啉单胞菌（Porphyromonas gingivalis）与具核梭杆菌（Fusobacterium nucleatum），在促进动脉粥样硬化、胰岛素抵抗及其他代谢紊乱的过程中发挥关键作用[2,5]。明晰口腔微生物与全身健康之间的复杂相互作用，或将助力预测性生物标志物与靶向干预手段的开发，凸显了口腔卫生与预防性牙科护理对维持整体健康的重要意义[1,3]。